1.Clinical features and SLC6A8 gene mutations of cerebral creatine deficiency syndrome I: an analysis of two families.
Wei-Hua SUN ; Dan-Yan ZHUANG ; Yao WANG ; Fei-Fan XIAO ; Meng-Yuan WU ; Xin-Ran DONG ; Ping ZHANG ; Hui-Jun WANG ; Wen-Hao ZHOU ; Bing-Bing WU
Chinese Journal of Contemporary Pediatrics 2020;22(5):482-487
This article reports the clinical and genetic features of two cases of cerebral creatine deficiency syndrome I (CCDSI) caused by SLC6A8 gene mutations. Both children were boys. Boy 1 (aged 2 years and 10 months) and Boy 2 (aged 8 years and 11 months) had the clinical manifestations of delayed mental and motor development, and convulsion. Their older brothers had the same symptoms. The mother of the boy 1 had mild intellectual disability. The genetic analysis showed two novel homozygous mutations, c.200G>A(p.Gly67Asp) and c.626_627delCT(p.Pro209Argfs*87), in the SLC6A8 gene on the X chromosome, both of which came from their mothers. These two novel mutations were rated as possible pathogenic mutations and were not reported in the literature before. This study expands the mutation spectrum of the SLC6A8 gene and has great significance in the diagnosis of boys with delayed development, and epilepsy.
Child
;
Child, Preschool
;
Creatine
;
Epilepsy
;
Genetic Testing
;
Humans
;
Male
;
Mutation
;
Nerve Tissue Proteins
;
genetics
;
Plasma Membrane Neurotransmitter Transport Proteins
;
genetics
;
Syndrome
2.Clinical and genetic analysis of a child with Cerebral creatine deficiency syndrome due to variant of SLC6A8 gene.
Yunjiang ZHANG ; Yifeng DING ; Yijie LI ; Shuizhen ZHOU
Chinese Journal of Medical Genetics 2023;40(11):1397-1403
OBJECTIVE:
To explore the clinical features and genetic variant in a child with Cerebral creatine deficiency syndrome (CCDS).
METHODS:
A child who had presented at the Affiliated Children's Hospital of Fudan University on March 5, 2021 was selected as the study subject. Whole exome sequencing (WES) was carried out for the child, and candidate variant was verified by Sanger sequencing. The level of creatine in the brain was determined by magnetic resonance spectroscopy.
RESULTS:
The patient, a 1-year-and-10-month male, had presented with developmental delay and epilepsy. Both his mother and grandmother had a history of convulsions. MRS showed reduced cerebral creatine in bilateral basal ganglia and thalamus. The child was found to harbor a hemizygous splicing variant of the SLC6A8 gene, namely c.1767+1_1767+2insA, which may lead to protein truncation. The variant was not found in the public databases. Both his mother and grandmother were heterozygous carriers for the same variant.
CONCLUSION
The hemizygous c.1767+1_1767+2insA variant of the SLC6A8 gene probably underlay the CCDS in this child. Discovery of the novel variant has also expanded the mutational spectrum of the SLC6A8 gene.
Humans
;
Male
;
Amino Acid Metabolism, Inborn Errors
;
Brain
;
Creatine/genetics*
;
Heterozygote
;
Mothers
;
Nerve Tissue Proteins
;
Plasma Membrane Neurotransmitter Transport Proteins/genetics*
;
Infant